365 related articles for article (PubMed ID: 15735050)
41. Distinct effects of the antiestrogen Faslodex on the stability of estrogen receptors-alpha and -beta in the breast cancer cell line MCF-7.
Peekhaus NT; Chang T; Hayes EC; Wilkinson HA; Mitra SW; Schaeffer JM; Rohrer SP
J Mol Endocrinol; 2004 Jun; 32(3):987-95. PubMed ID: 15171727
[TBL] [Abstract][Full Text] [Related]
42. Effects of 4-hydroxytamoxifen, raloxifene and ICI 182 780 on survival of uterine cancer cell lines in the presence and absence of exogenous estrogens.
Leblanc K; Sexton E; Parent S; Bélanger G; Déry MC; Boucher V; Asselin E
Int J Oncol; 2007 Feb; 30(2):477-87. PubMed ID: 17203231
[TBL] [Abstract][Full Text] [Related]
43. G-Protein-Coupled Estrogen Receptor Antagonist G15 Decreases Estrogen-Induced Development of Non-Small Cell Lung Cancer.
Liu C; Liao Y; Fan S; Fu X; Xiong J; Zhou S; Zou M; Wang J
Oncol Res; 2019 Feb; 27(3):283-292. PubMed ID: 28877783
[TBL] [Abstract][Full Text] [Related]
44. The AF-2 cofactor binding region is key for the selective SUMOylation of estrogen receptor alpha by antiestrogens.
Vallet A; El Ezzy M; Diennet M; Haidar S; Bouvier M; Mader S
J Biol Chem; 2023 Jan; 299(1):102757. PubMed ID: 36460099
[TBL] [Abstract][Full Text] [Related]
45. Identification of estrogen receptor beta expression in Chinese hamster ovary (CHO) cells and comparison of estrogen-responsive gene transcription in cells adapted to serum-free media.
Thomas PB; Risinger KE; Klinge CM
J Steroid Biochem Mol Biol; 2003 Jul; 86(1):41-55. PubMed ID: 12943744
[TBL] [Abstract][Full Text] [Related]
46. A bipartite recombinant yeast system for the identification of subtype-selective estrogen receptor ligands.
Liang K; Yang L; Xiao Z; Huang J
Mol Biotechnol; 2009 Jan; 41(1):53-62. PubMed ID: 18751932
[TBL] [Abstract][Full Text] [Related]
47. Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report.
Tekpli X; Skaug V; Bæra R; Phillips DH; Haugen A; Mollerup S
Cell Oncol (Dordr); 2016 Dec; 39(6):583-589. PubMed ID: 27572263
[TBL] [Abstract][Full Text] [Related]
48. Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein.
Saville B; Poukka H; Wormke M; Janne OA; Palvimo JJ; Stoner M; Samudio I; Safe S
J Biol Chem; 2002 Jan; 277(4):2485-97. PubMed ID: 11696545
[TBL] [Abstract][Full Text] [Related]
49. Changes in oestrogen receptor-alpha and -beta during progression to acquired resistance to tamoxifen and fulvestrant (Faslodex, ICI 182,780) in MCF7 human breast cancer cells.
Shaw LE; Sadler AJ; Pugazhendhi D; Darbre PD
J Steroid Biochem Mol Biol; 2006 Apr; 99(1):19-32. PubMed ID: 16533599
[TBL] [Abstract][Full Text] [Related]
50. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
Lau KM; LaSpina M; Long J; Ho SM
Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
[TBL] [Abstract][Full Text] [Related]
51. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
Ozers MS; Ervin KM; Steffen CL; Fronczak JA; Lebakken CS; Carnahan KA; Lowery RG; Burke TJ
Mol Endocrinol; 2005 Jan; 19(1):25-34. PubMed ID: 15375189
[TBL] [Abstract][Full Text] [Related]
52. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
Kim K; Thu N; Saville B; Safe S
Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
[TBL] [Abstract][Full Text] [Related]
53. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators.
Jaber BM; Gao T; Huang L; Karmakar S; Smith CL
Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538
[TBL] [Abstract][Full Text] [Related]
54. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
[TBL] [Abstract][Full Text] [Related]
55. Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform.
Waters KM; Rickard DJ; Riggs BL; Khosla S; Katzenellenbogen JA; Katzenellenbogen BS; Moore J; Spelsberg TC
J Cell Biochem; 2001 Aug 21-Sep 5; 83(3):448-62. PubMed ID: 11596113
[TBL] [Abstract][Full Text] [Related]
56. The antiestrogen ICI 182,780 decreases the expression of estrogen receptor-alpha but has no effect on estrogen receptor-beta and androgen receptor in rat efferent ductules.
Oliveira CA; Nie R; Carnes K; Franca LR; Prins GS; Saunders PT; Hess RA
Reprod Biol Endocrinol; 2003 Oct; 1():75. PubMed ID: 14613549
[TBL] [Abstract][Full Text] [Related]
57. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
58. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
[TBL] [Abstract][Full Text] [Related]
59. A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.
Watanabe M; Yanagisawa J; Kitagawa H; Takeyama K; Ogawa S; Arao Y; Suzawa M; Kobayashi Y; Yano T; Yoshikawa H; Masuhiro Y; Kato S
EMBO J; 2001 Mar; 20(6):1341-52. PubMed ID: 11250900
[TBL] [Abstract][Full Text] [Related]
60. Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma.
Verma MK; Miki Y; Abe K; Niikawa H; Sasano H
Expert Opin Ther Targets; 2012 Mar; 16 Suppl 1():S91-102. PubMed ID: 22313325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
